Anaphylactic risk associated with iodinated and gadolinium-based contrast media
This study provides clinicians and pharmacists evidence for risk signals of anaphylactic reactions among contrast agents.
Authors
- Kai Guan (ORCID: https://orcid.org/0000-0003-0850-5874)
- Le Cui (ORCID: https://orcid.org/0000-0002-1802-5981)
- Bin Zhao (ORCID: https://orcid.org/0000-0001-8555-523X)
- Yingyang Xu (ORCID: https://orcid.org/0000-0002-0583-1925)
- Zixi Wang (ORCID: https://orcid.org/0000-0001-8828-4228)
- Lisha Li (ORCID: https://orcid.org/0000-0002-1171-1858)
- Huadan Xue (ORCID: https://orcid.org/0000-0002-4278-2165)
- Sainan Bian
Institutions
- Academy of Medical Sciences (GB)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Precision for Medicine (United States) (US)
- National Clinical Research (US)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1080/14740338.2024.2435431
- Citations
- 1
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 0.53
Funders
- National Natural Science Foundation of China